Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced
Is less regulation by the Food and Drug Administration good for the biotech industry? Do vaccine makers like Pfizer have a target on their back
Pancreatic ductal adenocarcinoma (PDAC) is recognized as one of the most lethal cancers, with an estimated five-year survival rate of approximately 10%.
When thinking about the immune system, most people think about B and T cells and how they can be trained to recognize pathogens, preventing re-infections.
For months, as human cases of H5N1 bird flu associated with an outbreak of the virus in U.S. dairy cattle have mounted, one question has
A virulent new strain of antibiotic-resistant bacteria that causes severe disease could be spreading widely across Asia – posing significant challenges to global public health,
Jeff Geier, Cyber Security Leader at Pivotalogic California’s bold new CalAIM Medicaid transformation program is restructuring what partnership for health looks like across the state.
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Johnson & Johnson received Food
Listen to the article 8 min This audio is auto-generated. Please let us know if you have feedback. Donald Trump’s victory in the U.S. presidential
Siemens Healthineers CEO Bernd Montag said Wednesday the company is “very, very well positioned” for “a U.S. versus China situation” that could arise when Donald